Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • frymor
    Senior Member
    • May 2010
    • 151

    #1

    Pol III chip-seq experimental design

    hi all,
    we are planning on doing a ChIP-Seq experiment trying to identify PolIII binding sites in yeast and mouse.
    As I am not really sure of the binding affinity of PolII I would like to ask for your opinions.

    First a general question. I know PolII has a mixed binding pattern (narrow and broad BS). But I am not sure about Pol3. Does it also have a mixed behavior or is it more similar to the point-source factors (TF)?

    I would also like to ask for your opinion as to how deep to sequence and how many replicate are necessary to hope for good and valid results.
    I know the Encode consortium recommend 20M mapped reads for human for point-source Binding events, but as we are talking about a possible mixed behavior and also partially doing it in yeast, I was wondering how many reads are necessary for these two organisms?

    Another question I have just thought of is about the control. Which control samples are better - IgG controls with "mock" antibody, or the input Samples from similar cells, but without the antibody?
    Which of the two controls are better for the this kind of analysis? As fat as I know, there are no tools, who can work with both of them.

    Thanks in advance for any help

    Assa
    Last edited by frymor; 11-22-2017, 06:45 AM. Reason: further question

Latest Articles

Collapse

  • SEQadmin2
    Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
    by SEQadmin2



    Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

    Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
    ...
    10-14-2026, 09:55 AM
  • SEQadmin2
    New Genomics Technologies Take Aim at Long-Standing Limits
    by SEQadmin2


    Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.

    We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing
    ...
    09-28-2026, 10:25 AM

ad_right_rmr

Collapse

News

Collapse

Topics Statistics Last Post
Started by SEQadmin2, 10-22-2026, 11:13 AM
0 responses
25 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-22-2026, 10:48 AM
0 responses
20 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-15-2026, 10:52 AM
0 responses
36 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-14-2026, 05:39 AM
0 responses
42 views
0 reactions
Last Post SEQadmin2  
Working...